Acebutolol

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aldesleukin, Alpha blockers, Alprostadil, Amiodarone, Angiotensin II receptor antagonists, Antiarrhythmics, Antidiabetics, Anxiolytics and hypnotics, Baclofen, Calcium channel blockers, Cardiac glycosides, Clonidine, Corticosteroids, Diazoxide, Diltiazem, Disopyramide, Diuretics, Ergotamine, Estrogens, Flecainide, General anesthetics, Hydralazine, Insulin, Levodopa, MAO inhibitors, Mefloquine, Methyldopa, Methysergide, Minoxidil, Moxisylyte, Moxonidine, Nifedipine, Nitrates, Nitroprusside, NSAIDs, Phenothiazines, Pilocarpine, Prazosin, Tizanidine, Verapamil

PREGNANCY CATEGORY: B

Contraindicated in persistently severe bradycardia. second- and third-degree heart
block, overt cardiac failure, and cardiogenic shock.

Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.

Our database has 57 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top